ZMUni Compliance Centre

On April 24, 2025, China's State Administration for Market Regulation (SAMR) issued a public consultation on the draft "Catalog of Permitted Health Claims for Health Foods: Aids in Maintaining Joint Health." Stakeholders are invited to submit their feedback by June 2, 2025   This marks the first new health function proposed to be included in the official health claim catalog since the issuance of the “Implementation Rules for the Evaluation of New Health Functions and Product Technologies of Health Foods (Trial)”.   The newly proposed function, “aids in maintaining joint health,” encompasses several specific benefits, including alleviating joint pain and

  To help overseas companies stay up to date with cosmetic ingredient trends in China, ZMUni Compliance Centre will publish a regular series on New Cosmetic Ingredient (NCI) notifications. We hope this provides valuable insights for ingredient suppliers and brands looking to enter the Chinese market.     From April 11 to 21, 2025, 2 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN Notification No. Notifier in CN 透明质酸水杨酸酯钠 202500035 华熙生物科技股份有限公司 N-乙酰基-丝氨酰-脯氨酰-缬氨酰-异亮氨酰-缬氨酰-脯氨酰胺 202500036 北京茂思商贸有限公司   The technical requirements for the 2 new cosmetic ingredients mentioned above have not been disclosed, and they have not

To help overseas companies stay up to date with cosmetic ingredient trends in China, ZMUni Compliance Centre will publish a regular series on New Cosmetic Ingredient (NCI) notifications. We hope this provides valuable insights for ingredient suppliers and brands looking to enter the Chinese market.     From April 1st to 10th, 2025, 4 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN&EN Notification No. Notifier in CN 乙酰基三肽-30 瓜氨酸 Acetyl Tripeptide 30 Citrulline 202500031 深圳市护家科技有限公司 红景天苷 Salidroside 202500032 上海华茂药业有限公司 昙花（Epiphyllum oxypetalum）愈伤组织提取物 Epiphyllum Oxypetalum Callus Extract 202500033 杭州拾光欣雅有限公司 苦丁茶（ILEX KUDINGCHA）叶提取物 ILEX KUDINGCHA Leaf Extract 202500034 广州袋鼠妈妈科技创新研究有限公司

      On April 10, 2025, China's National Institutes for Food and Drug Control (NIFDC) released the Information on the Use of Some Ingredients Included in the Index of International Cosmetic Safety Assessment Data, along with a corresponding Q&A.   Developed in response to industry needs, this document builds upon the Ingredient Usage Information of Marketed Products released by NIFDC on February 9, 2025. It focuses on ingredients listed in the Index of International Cosmetic Safety Assessment Data that are frequently used in registered or notified cosmetics in China, particularly those lacking definitive safety conclusions or subject to usage restrictions. The update

This article focuses on summarizing the regulatory developments related to food within China and internationally in March 2025, with an emphasis on updates in regulations concerning new food ingredients, food additives, feed additives, and health foods.     China Food Regulatory Updates Three New Food   On March 21, 2025, China National Center for Food Safety Risk Assessment (CFSA) released a notice seeking public comments on eight new food additive varieties. Comments are welcome until April 20, 2025. For more details, see here.   On March 21, 2025, China CFSA issued a public consultation on four new food ingredients: Lutein esters, D-Psicose/D-Allulose, Bifidobacteriumanimalis subsp.lactis BLa80,

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics within China and globe in March 2025, with an emphasis on updates in cosmetic ingredient, cosmetic notification, labeling, etc.     China Cosmetic Regulatory Updates New Cosmetics Ingredients (NCI) Notification   In March 2025, 11 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN and EN Notification No. Notifier 铁皮石斛（DENDROBIUM OFFICINALE）培养物 20250020 沈阳科康科技有限公司 HDI/二 C12-14 醇酒石酸酯/氢化二聚亚油醇共聚物 Hdi/di-c12-14 Alkyl Tartrate/hydrogenated Dilinoleyl Alcohol Copolymer 20250021

  As of March 2025, 237 new cosmetic ingredients (NCIs) have been successfully notified in China, with one ingredient approved for registration. In Q1 2025, 30 NCIs were newly notified. With the implementation of new regulations in February, innovation in cosmetic ingredients is expected to accelerate, and the total number of notified NCIs in 2025 is likely to exceed 100.   Overview In Q1 2025, no new cosmetic ingredient (NCI) have been publicly registered yet, but the number of NCI notifications continues to rise. According to data from China’s National Medical Products Administration (NMPA), a total of 30 NCIs were notified this quarter,

  On March 27, 2025, China National Institutes for Food and Drug Control (NIFDC) released the Technical Guidelines for Updating New Cosmetic Ingredient Notification Informarion (Draft for Comments) for public consultation. The deadline for public feedback is April 15, 2025.   The Draft Guidelines applies to the update of notification information for NCI within their 3-year safety monitoring period, while registered NCI may also refer to this Guidelines. Updates are prohibited within the last six months of the monitoring period, and any identified safety risks must be reported immediately.   The Draft Guidelines categorizes permissible updates into three levels based on risk assessment: 1. Routine updates to self-maintained information. 2. Updates to company-related information,